Acasti Pharma Stock Market Value
| ACST Stock | USD 2.73 0.03 1.11% |
| Symbol | Acasti |
Acasti Pharma Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.68) | Revenue Per Share 0.005 | Return On Assets (0.08) | Return On Equity (0.48) |
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acasti Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Acasti Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Acasti Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Acasti Pharma.
| 03/05/2024 |
| 06/03/2024 |
If you would invest 0.00 in Acasti Pharma on March 5, 2024 and sell it all today you would earn a total of 0.00 from holding Acasti Pharma or generate 0.0% return on investment in Acasti Pharma over 90 days. Acasti Pharma is related to or competes with Valneva SE, Dominari Holdings, Procter Gamble, HP, JPMorgan Chase, 3M, and GE Aerospace. Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical prod... More
Acasti Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Acasti Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Acasti Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 10.81 | |||
| Value At Risk | (4.50) | |||
| Potential Upside | 2.99 |
Acasti Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acasti Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Acasti Pharma's standard deviation. In reality, there are many statistical measures that can use Acasti Pharma historical prices to predict the future Acasti Pharma's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.52) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acasti Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acasti Pharma Backtested Returns
Acasti Pharma secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of standard deviation over the last 3 months. Acasti Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Acasti Pharma's mean deviation of 1.5, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.61, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Acasti Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Acasti Pharma is expected to be smaller as well. At this point, Acasti Pharma has a negative expected return of -0.33%. Please make sure to confirm Acasti Pharma's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Acasti Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.07 |
Virtually no predictability
Acasti Pharma has virtually no predictability. Overlapping area represents the amount of predictability between Acasti Pharma time series from 5th of March 2024 to 19th of April 2024 and 19th of April 2024 to 3rd of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Acasti Pharma price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Acasti Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | -0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Acasti Pharma lagged returns against current returns
Autocorrelation, which is Acasti Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Acasti Pharma's stock expected returns. We can calculate the autocorrelation of Acasti Pharma returns to help us make a trade decision. For example, suppose you find that Acasti Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Acasti Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Acasti Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Acasti Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Acasti Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Acasti Pharma Lagged Returns
When evaluating Acasti Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Acasti Pharma stock have on its future price. Acasti Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Acasti Pharma autocorrelation shows the relationship between Acasti Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Acasti Pharma.
Regressed Prices |
| Timeline |
Pair Trading with Acasti Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acasti Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Acasti Stock
| 0.84 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.84 | ELDN | Eledon Pharmaceuticals | PairCorr |
| 0.76 | HCM | HUTCHMED DRC | PairCorr |
| 0.67 | DSGN | Design Therapeutics | PairCorr |
| 0.41 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Acasti Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acasti Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acasti Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acasti Pharma to buy it.
The correlation of Acasti Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acasti Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acasti Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acasti Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Acasti Stock Analysis
When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.